Highest-materiality recent filing
15 states and one sovereign sued in the U.S. District Court for the Southern District of Indiana on Oct 1, 2026, challenging Corteva's separation from Vylor Inc. and seeking injunctive relief.
Corteva completed the separation of its seed operating segment into independent public company Vylor Inc. at 12:03 a.m. New York City time on October 1, 2026.
Vylor completes EIDP note exchange offers; indenture amendments operative Oct. 1, 2026
Vylor Inc. completed exchange offers on Oct. 1, 2026 for EIDP senior notes; accepted amounts included $434,839,000 of 2.300% notes due 2030.
Corteva completes spin-off of seed unit Vylor; VYLR begins NYSE trading Oct 1
Corteva completed separation of its seed operating segment into independent public company Vylor Inc. at 12:03 a.m. NYC time on Oct 1, 2026.
Corteva completes Seed Business spin-off into Vylor; New Corteva posts $3.85B H1 net sales
Corteva completed the separation of its Seed Business into independent publicly traded Vylor Inc. on Oct. 1, 2026, via pro rata dividend of all Vylor shares to holders of record Sept. 24, 2026.
Corteva completes spin-off of seed unit Vylor; VYLR to begin NYSE trading Oct 1
Corteva completed the separation of its seed operating segment into independent, publicly traded Vylor Inc. via pro rata distribution of Vylor common stock to Corteva shareholders.
Corteva: EIDP note exchange draws 86.97%-95.24% tenders; separation expected Oct 1, 2026
Vylor Inc., Corteva's wholly owned sub, received final results of exchange offers for EIDP notes; expiration was 5 p.m. NYC time Sept 30, 2026.
Fourth Circuit summarily reversed the District Court's order denying California leave to seek a TRO; on remand the District Court denied California's motion to enjoin the Separation.
Vylor Inc., Corteva's subsidiary, extended the expiration of its private exchange offers and consent solicitations for EIDP notes from 5:00 p.m. NYC time Sept 29, 2026 to 5:00 p.m. Sept 30, 2026.
Corteva said the SEC declared effective Vylor's Form 10 registration statement; separation into an independent public company is expected to complete on October 1, 2026.
EIDP issues $700M of 6.000% senior notes due 2036 tied to Corteva separation
EIDP, Inc. issued $700M aggregate principal of senior notes due Aug 15, 2036, at 6.000% interest.
Corteva subsidiary Vylor files Form 10 Amendment No. 3 for seed business spin-off
On Sept 21, 2026, Vylor, Inc., a Corteva subsidiary, filed Amendment No. 3 to its Form 10 registration statement with the SEC.
Corteva board approves Vylor spin-off; record date Sep 24, distribution Oct 1
Corteva to distribute 1 share of Vylor common (VYLR) per CTVA share to holders of record Sep 24, 2026.
Corteva, Chemours, DuPont settle NC PFAS claims for $455M; Corteva share ~$66M
Settlement with NC AG and 10 local entities resolves statewide PFAS and Fayetteville Works claims; no admission of liability.
Vylor raises $1.1B senior notes for Corteva seed business separation
Issued $550M 5.125% senior notes due 2031 and $550M 5.625% senior notes due 2036.
Corteva advances separation; EIDP noteholders consent to indenture amendments
Vylor received requisite consents for EIDP Notes (2.300% 2030, 5.125% 2032, 4.800% 2033) to amend indenture.
Corteva extends EIDP debt exchange offers to Sep 29; early tenders 86-94%
Early tender results: 2.300% notes due 2030 tendered $431.6M (86.33%); 5.125% notes due 2032 $468.4M (93.69%); 4.800% notes due 2033 $524.9M (87.48%).
Corteva subsidiary Vylor files amended Form 10 for seed business spin-off
Vylor, Inc., a Corteva subsidiary, filed first amendment to Form 10 on Aug 14, 2026.
Vylor expects debt/EBITDA leverage ratio of 0.8x-1.1x at Dec 31, 2026, targeting not to exceed 2.5x.
Corteva raises FY2026 guidance after strong 1H; Q2 operating EPS $2.30
Q2 GAAP EPS $1.81 vs $2.02 YoY; operating EPS $2.30, up 5% YoY.
Corteva announces post-spin-off boards for Corteva and Vylor; Q4 2026 separation on track
Four directors (Grimes, Lutz, Magro, Preete) resign from Corteva board to join Vylor board upon spin-off.
Corteva revises restructuring charges to $750M-$815M, adds Spain plant closure
Pre-tax charges now $750M-$815M, up $100M-$115M from prior estimate.
Corteva Delivers Strong Q1 2026: EPS $1.07 GAAP, $1.50 Operating; Reaffirms FY Outlook
Net sales $4.905B (+11% YoY); organic sales +7%. GAAP net income $725M ($1.07 EPS).
Corteva stockholders elect all 12 director nominees and approve say-on-pay at 2026 annual meeting
All 12 director nominees elected with strong majority support; broker non-votes 51.6M.
Corteva names Luke Kissam CEO of New Corteva; reveals SpinCo leadership for planned separation
Luke Kissam, former Albemarle CEO, to lead New Corteva (crop protection) at Q4 2026 spin-off; joins June 1 as crop protection BU CEO.
Corteva FY2025 sales $17.4B (+3%), EBITDA $3.85B; guides 2026 EBITDA $4.0-4.2B; settles Bayer
Full-year GAAP EPS from cont ops $1.75, up 43% YoY; Operating EPS $3.34, up 30%.
Corteva raises FY2025 guidance; Q3 op EBITDA $49M; plans spin-off in H2 2026
Q3 net sales $2.62B, +13% YoY; GAAP loss $308M (loss $0.46) vs loss $519M prior year.
Corteva to split into two public companies via tax-free spin-off by H2 2026
Board unanimously approved plan to separate into two independent public companies via tax-free spin-off expected in H2 2026.
Corteva appoints Jennifer Johnson Chief Legal Officer; Cornel Fuerer to retire in 2026
Jennifer Johnson becomes SVP, Chief Legal Officer effective Sept 15, 2025, succeeding Cornel Fuerer.
Corteva Q2 GAAP EPS $2.02, op EPS $2.20; raises FY2025 guidance
Q2 GAAP EPS $2.02 (up 34% YoY); operating EPS $2.20 (up 20%).
Corteva Q1 2025: EPS $0.97 GAAP, $1.13 operating; reaffirms FY guidance
GAAP EPS $0.97 from cont. ops (+83% YoY); operating EPS $1.13 (+27% YoY).
Corteva stockholders elect all 12 director nominees, approve say-on-pay, ratify PwC
All 12 director nominees elected; average ~98.2% votes for across candidates (excluding broker non-votes).
Corteva director Rebecca Liebert resigns, effective Feb 28, 2025
Rebecca Liebert, Ph.D. informed board on Feb 13, 2025 of resignation to pursue other opportunities.
GAAP diluted EPS from continuing ops -$0.08 in Q4 vs -$0.33 a year ago; Operating EPS $0.32, up 113% YoY.
Corteva reports Q3 loss, updates FY guidance, announces restructuring cost increase
Q3 2024 net sales $2.33B (-10% YoY); GAAP loss from cont. ops $519M; GAAP EPS -$0.76.
Corteva names Judd O'Connor EVP Seed Business Unit as Tim Glenn retires Dec 1, 2024
Tim Glenn will retire effective December 1, 2024, and serve as strategic advisor through Q1 2025.
Corteva Q2 GAAP EPS $1.51, up 23% YoY; cuts FY guidance; names new CFO
Seed EBITDA +16% to $1.70B on 5% price lift; Crop Protection EBITDA -20% to $255M on pricing pressure.
Corteva stockholders approve officer exculpation amendment at annual meeting
All 13 director nominees elected with >94% support from votes cast, excluding broker non-votes.
Corteva Q1 net sales down 8% to $4.49B, EPS $0.53; reaffirms FY guidance
GAAP EPS from continuing ops $0.53 vs $0.84 prior year; operating EPS (non-GAAP) $0.89 vs $1.16.
Q4 net sales $3.71B (-3% YoY); GAAP loss from cont. ops $231M (EPS -$0.33).
Corteva Q3 net loss $315M; affirms FY guidance; announces $410-460M restructuring
Q3 net loss from continuing ops $315M, diluted EPS -$0.45; organic sales down 13% vs prior year.
Corteva lowers FY2023 guidance on Brazil headwinds; Q3 GAAP loss $0.45/sh
Q3 preliminary net sales ~$2.6B; GAAP loss from ops ~$315M (EPS $0.45).
Corteva Q2 GAAP EPS $1.23, cuts FY guidance; Seed EBITDA +18%, Crop Protection -37%
Q2 net sales $6.05B (-3% YoY); GAAP EPS $1.23 (-10%); Operating EPS $1.60 (-2%).
Corteva subsidiary EIDP issues $1.2B in senior notes at 4.500% and 4.800%
EIDP, Inc. issued $600M 4.500% Senior Notes due 2026 and $600M 4.800% Senior Notes due 2033.
Corteva Q1 organic sales up 10% to $5.06B; raises FY2023 guidance on strong price execution
GAAP EPS $0.84 vs $0.79 YoY; Operating EPS $1.16 vs $0.97, up 20% on price and productivity.
Corteva shareholders elect 13 directors, approve executive compensation, ratify PwC as auditor
All 13 director nominees elected; highest votes for Charles V. Magro (560.6M for), lowest for Gregory R. Page (514.7M for).
Q4 GAAP loss from continuing ops $41M, EPS -$0.06; operating EPS $0.16 (+100% YoY).
Corteva amends bylaws to align with universal proxy rules and Delaware law
Board approved Second Amended and Restated Bylaws effective December 15, 2022.
Corteva reports Q3 GAAP loss $322M; raises full-year EBITDA mid-point; to acquire Symborg
Q3 net sales $2.78B (+17% YoY); GAAP EPS $(0.45); operating EBITDA $96M vs ($51M) prior year.
Corteva Q2 sales $6.25B (+11% YoY), raises full-year EPS guidance to $2.45-$2.60
Q2 GAAP EPS $1.37 (flat YoY); Operating EPS $1.64 (+17%) on strong price execution.
each of Mr. Magro, David P. Johnson, Samuel R. Eathington, Ph.D. and Judd M. O’Connor resigned from their respective positions as officers of the Company, effective as of the Effective Time.
Mr. Kissam was appointed as Chief Executive Officer of the Company
In connection with the Separation, the Board appointed Luther (“Luke”) Kissam as a director of the Company effective as of the Effective Time.
each of Mr. Magro, David P. Johnson, Samuel R. Eathington, Ph.D. and Judd M. O’Connor resigned from their respective positions as officers of the Company, effective as of the Effective Time.
Jeff Rudolph was appointed as Chief Financial Officer of the Company
Additionally, each of Kerry J. Preete, Marcos M. Lutz and Karen H. Grimes resigned from their respective positions as members of the Board, as well as their respective positions as members of various Committees thereof, in each case, effective as of the Effective Time.
each of Mr. Magro, David P. Johnson, Samuel R. Eathington, Ph.D. and Judd M. O’Connor resigned from their respective positions as officers of the Company, effective as of the Effective Time.
Additionally, each of Kerry J. Preete, Marcos M. Lutz and Karen H. Grimes resigned from their respective positions as members of the Board, as well as their respective positions as members of various Committees thereof, in each case, effective as of the Effective Time.
In connection with the Separation, Charles V. Magro resigned from his position as a member of the Company’s Board of Directors (the “Board”) effective as of the Effective Time.
Ralph Ford was appointed as Chief Integrated Operations Officer of the Company
Brook Cunningham was appointed as Chief Commercial Officer of the Company
Additionally, each of Kerry J. Preete, Marcos M. Lutz and Karen H. Grimes resigned from their respective positions as members of the Board, as well as their respective positions as members of various Committees thereof, in each case, effective as of the Effective Time.
Max materiality 0.90 · Median 0.70 · Most common event earnings